CHAMGAP
APPROVEDReviewed and approved by the Chamgap Editorial Team (2026-08-18). The draft was written by AI, the existence of all 1 cited sources was verified at the original page, and the verdict passed blind grading and adversarial audit. Methodology v0.7.
Verdict No. 2767 · Search date 2026-08-18 · Methodology v0.7

Early tracheostomy,
does it really help with Reduced 30-day mortality in adults expected to require prolonged mechanical ventilation?

30-Second Summary
D
Evidence Grade D · 34 · Safety caution
Early tracheostomy did not improve survival, and waiting spared many procedures
Acute tracheostomy complications occurred in 6.3% of procedures, most commonly bleeding requiring intervention. The article also reported one esophageal perforation.
What the
research shows
The grade is D. In TracMan, 30-day mortality was 139/451 (30.8%) with early tracheostomy versus 141/448 (31.5%) when tracheostomy was delayed until day 10 and performed only if still needed. The absolute risk reduction was 0.7 points (95% CI -5.4 to 6.7), RR 0.98 (0.81 to 1.19), p=0.89. Recruitment stopped at 909 rather than 1,692 because of recruitment fatigue and exhausted funding, leaving meaningful benefit possible in a single trial and giving D with 34 points.
What the
ads claim
The trial does not support a claim that earlier airway access improves survival. It supports saying that mortality was unchanged and that waiting until day 10 spared more than half of the delayed group from tracheostomy.
*

Useful facts when choosing a product

  • Early meant within four days; delayed meant day 10 or later and only if still indicated.
  • Only 44.9% of the delayed group underwent tracheostomy.
  • Recruitment ended for resource reasons, not after crossing an efficacy or harm boundary.
Gap Measurement · Verdict 2767 · D 34
What advertising claims
What independent, higher-quality research supports
△ GAP
01

What the research actually shows

Across 72 UK ICUs, 909 patients were assigned, 455 early and 454 delayed. After duplicate randomization and withdrawals, the primary analysis included 451 versus 448. ‘Randomization was conducted using an automated 24-hour telephone service,’ main analyses followed an a priori intention-to-treat plan, and survival came from UK death registers. The target was 1,692, but ‘study fatigue’ and ‘exhaustion of funding’ prevented completion; the steering committee stopped for ‘practical rather than for statistical reasons.’ This was resource-limited early stopping. The UK Intensive Care Society and Medical Research Council funded the study, no conflicts were reported, and no company-supplied tracheostomy material or assessment tool was identified.

02

Why this is classified as D (34)

A large publicly funded hard-outcome trial was null, and resource-limited early stopping left benefit possible, giving D with 34 points.

Counterpoint. This is a null survival verdict, not a prohibition of early tracheostomy for every airway-management circumstance.

Rejudgment record. Cross-check applied — Accounts for the absolute 30-day mortality difference, the 899-person primary analysis, and practical resource-limited stopping rather than a statistical boundary

Scoring profile behind this grade
EndpointHHard endpoint - actual events such as death
ReplicationR1Single confirmatory trial
IndependenceI2Decisive evidence is publicly or non-profit funded
Effect sizeE0Null
PrecisionC0The confidence interval leaves room for benefit

The scoring table and the verdict agree (D).

Sub-claim grades by effect

This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.

Effect (sub-claim)GradeBasis
Tracheostomy within four days reduces 30-day mortalityDMortality was 30.8% versus 31.5%, RR 0.98, with no benefit.
Waiting until day 10 avoids unnecessary tracheostomyBOnly 44.9% of the delayed group underwent tracheostomy.

Cross-check — Codex and Claude

This verdict was drafted by Codex through literature review and source-existence checks, cross-checked through blind grading and adversarial audit, and settled by reapplying the methodology boundary rules. Cases with split grades were resolved through rejudgment.
03

Evidence Table

StudyDesignSampleFundingEndpointResultWeight
Study 1Open pragmatic randomized trial in 72 UK ICUs448Public and nonprofit funding from the UK Intensive Care Society and Medical Research Council; no company-supplied trial material or assessment toolAll-cause mortality 30 days after randomization139/451 (30.8%) versus 141/448 (31.5%); absolute risk reduction 0.7 points (95% CI -5.4 to 6.7); RR 0.98 (0.81 to 1.19), p=0.89Null publicly funded hard-outcome trial with resource-limited early stopping
§

Receipt — 1 References

All 1 cited sources were verified for existence at the original page (as of 2026-08-18).

Young D, Harrison DA, Cuthbertson BH, et al. Effect of Early vs Late Tracheostomy Placement on Survival in Patients Receiving Mechanical Ventilation: The TracMan Randomized Trial. JAMA. 2013;309(20):2121-2129. PMID: 23695482. DOI: 10.1001/jama.2013.5154. ISRCTN28588190.
checked
Draft and rewrite: Codex (AI) · Verification: Codex blind grading and adversarial audit · Final adjudication: Claude
Reviewed and approved: Chamgap Editorial Team · Approval date: 2026-08-18 · Corrections: none

Cite this verdict

Early tracheostomy x 30-day mortality in patients expected to need prolonged ventilation Evidence Grade D card
[Chamgap] Early tracheostomy x 30-day mortality in patients expected to need prolonged ventilation — Evidence Grade D·34. 1 cited sources checked. Source: https://chamgap.com/en/verdicts/general/early-versus-late-tracheostomy-prolonged-ventilation-30-day-mortality/ · CC BY 4.0

CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.

!

What this document does and does not do

Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.